Tag: Metformin risks

Janumet, a medication for type 2 diabetes, combines metformin and sitagliptin, but comes with significant drawbacks. A critical disadvantage of Janumet is the potential for serious side effects, such as the rare but fatal lactic acidosis, which carries the FDA's most serious warning.

The American Diabetes Association consistently recommends metformin as a first-line therapy for type 2 diabetes. However, the notion that some doctors are “against” metformin often stems from valid, specific safety concerns rather than a general disapproval of this highly effective medication.